Casodex and Serevent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Casodex and Serevent. Common interactions include dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Casodex and Serevent have. It is created by eHealthMe based on reports of 29 people who take Casodex and Serevent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

29 people who take Casodex and Serevent together, and have interactions are studied.

What is Casodex?

Casodex has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 10,303 Casodex users for its effectiveness, alternative drugs and more.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,291 Serevent users for its effectiveness, alternative drugs and more.

Number of Casodex and Serevent reports submitted per year:

Common Casodex and Serevent drug interactions by gender *:

female:

n/a

male:

Dyspnoea
Pneumonia
Decreased interest
Diabetes mellitus
Disability
Gastrooesophageal reflux disease
General physical health deterioration
Haemoptysis
Intervertebral disc protrusion
Lung infiltration

Common Casodex and Serevent drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Pneumonia
Pulmonary fibrosis
Decreased interest
Diabetes mellitus
Disability
Gastrooesophageal reflux disease
General physical health deterioration
Haemoptysis
Intervertebral disc protrusion
Lung infiltration

Common conditions people have *:

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 17.24%
Respiratory Tract Infection: 4 people, 13.79%
Insomnia (sleeplessness): 4 people, 13.79%
High Blood Pressure: 4 people, 13.79%
Gastritis (inflammation of stomach): 4 people, 13.79%
Gastric Ulcer (stomach ulcer): 4 people, 13.79%
Constipation: 4 people, 13.79%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 6.90%
Parkinson's Disease: 2 people, 6.90%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Casodex and Serevent?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .